In an increasingly competitive and data-driven business world, organizations must rely on accurate insights to guide their strategies and decisions. Understanding market behavior, tracking industry developments, and identifying growth opportunities are no longer optional—they are essential for survival and long-term success. Recognizing this growing demand for reliable intelligence, Emergen Research has launched its comprehensive Continuous Glucose Monitoring market research content, a powerful resource designed to support businesses across various industries.
One of the most notable aspects of this research is its strong focus on delivering actionable insights. Instead of simply presenting large volumes of raw data, the report is structured to help businesses translate information into practical strategies. Whether a company is planning expansion, optimizing operations, or exploring new opportunities, the recommendations provided in this content can play a crucial role in guiding decision-making processes.
The Continuous Glucose Monitoring market is expected to grow from an estimated USD 5.1 billion in 2025 to USD 14.4 billion in 2035, at a CAGR of 12.20%.
The rise in diabetes prevalence due to ageing, obesity, and an unhealthy lifestyle is one of the factors driving the continuous glucose monitoring (CGM) device market. Obesity is a key contributor to diabetes.
According to the World Health Organization, the global obesity rate will approach 1 billion in 2022, comprising 650 million adults, 340 million adolescents, and 39 million children. This figure continues to rise. If current trends continue, the World Health Organization projects that by 2025, around 167 million individuals, both adults and children, will have worsening health problems as a result of their weight difficulties. In addition to obesity, diabetes is becoming more common worldwide.
According to the International Diabetes Federation (IDF), 537 million adults (aged 20-79) had diabetes in 2021, with that figure predicted to rise to 642 million by 2040. According to the IDF, diabetes is becoming more common all over the world, with low- and middle-income countries experiencing the greatest growth.
The rising incidence of prediabetes is also driving market expansion. Prediabetes is a condition in which blood sugar levels are higher than usual but not high enough to be diagnosed with type 2 diabetes. It is a dangerous medical disorder that raises the chance of acquiring type 2 diabetes, heart disease, and stroke. Unfortunately, the number of persons diagnosed with prediabetes is increasing fast.
The primary cause of the increase in prediabetes instances is the rise in obesity prevalence. Obesity is a significant risk factor for prediabetes and type 2 diabetes. As more people embrace sedentary lifestyles and eat poor diets, the prevalence of obesity rises, increasing prediabetes. According to the CDC and the US Department of Health and Human Services, it is anticipated that 97.6 million adults in the United States aged 18 and up will have prediabetes in 2021.
The Continuous Glucose Monitoring market research content has been developed through a rigorous process that combines advanced data analytics with deep industry expertise. Emergen Research’s team of analysts has carefully studied historical data, current trends, and future projections to create a comprehensive and reliable resource. The content includes a wide range of materials such as detailed market reports, whitepapers, case studies, and trend analyses. These resources cover multiple sectors including healthcare, technology, finance, manufacturing, and consumer goods, ensuring that the insights are relevant to businesses operating in diverse markets.
Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-free-sample/4417
Competitive landscape:-
The report also provides a comprehensive overview of the competitive landscape, which is critical for businesses aiming to maintain a strong market position. It highlights key players in the global Continuous Glucose Monitoring market and offers insights into their strategies, strengths, and recent developments. Information related to mergers and acquisitions, collaborations, technological advancements, and product launches is also included. This helps businesses understand how competitors are evolving and identify opportunities to differentiate themselves.
Rise in burden of diabetes to propel market growth
The rising prevalence of diabetes is a primary growth factor in the continuous glucose monitoring (CGM) market. As diabetes spreads around the world, more people seek effective ways to keep blood glucose levels stable. CGM systems empower users with the opportunity to make informed decisions about their food, exercise, and medicine, ultimately improving health outcomes.
The expanding knowledge of diabetes management, combined with healthcare professionals’ increased emphasis on glucose monitoring as a normal practice, fuels demand for CGM devices. Technological advancements have also simplified and made these systems more accessible to patients, encouraging their adoption. This growing emphasis on proactive diabetes care is projected to propel the CGM industry in the coming years.
For instance, the International Diabetes Federation (IDF) reports that over 537 billion individuals (aged 20 to 79 years) worldwide have diabetes, which is projected to increase to over 643 billion by 2030 and over 783 billion by 2045. This, in turn, is projected to drive up global usage of continuous glucose monitoring devices.
Another significant feature of the report is its detailed segmentation analysis. By dividing the Continuous Glucose Monitoring market into various categories such as product types, applications, end-user industries, and geographical regions, the report provides a deeper understanding of how different segments perform. This enables businesses to identify high-growth areas and focus their strategies accordingly. Understanding these segment-level dynamics can help organizations optimize resource allocation and improve overall efficiency.
The CGM industry represents a rapidly progressing sector focusing on providing real-time data on blood glucose levels in individuals who have diabetes. The user can use the CGM system for continuous tracking of glucose levels, thus ensuring better control over the disorder and, subsequently, better health outcomes.
Leading companies in the industry include Dexcom, Abbott Laboratories, and Medtronic, which specialise in novel technology and highly user-friendly devices. The increasing incidence of diabetes, coupled with the awareness of the need for glucose control, is driving the demand for CGM systems. Furthermore, the integration of smartphones and data analytics is further enhancing the appeal of CGM solutions in the healthcare market.
In January 2025, Medtronic plc announced that its MiniMed 780G system with Simplera Sync had obtained CE Mark clearance. Simple Sync is a technique that improves the user experience by simplifying the two-step insertion process. In addition, this new sensor is half the size of its predecessors.
The MiniMed 780G system with Simplera Sync sensor is expected to launch in Europe via a limited release in the spring of 2025, followed by a phased commercial introduction in the summer of the same year.
Some of the key companies in the global Continuous Glucose Monitoring Market include:
- Dexcom, Inc.
- Abbott
- Medtronic
- Ypsomed AG
- Senseonics Holdings, Inc.
- A. Menarini Diagnostics S.r.l.
- Signos, Inc.
Custom Requirements can be requested for this Report [Customization Available] @ https://www.emergenresearch.com/request-for-customization/4417
Beyond competitive and segmentation analysis, the report is designed to cater to a wide range of stakeholders. Investors, venture capitalists, startups, and large enterprises can all benefit from the insights provided. Additionally, consulting firms, research organizations, and government bodies can use the information to support policy-making and strategic planning.
-
Component Outlook (Revenue, USD Billion; 2020-2035)
- Transmitters
- Sensors
- Receivers
-
Connectivity Outlook (Revenue, USD Billion; 2020-2035)
- Bluetooth
- 4G
-
Vertical Outlook (Revenue, USD Billion; 2020-2035)
- Hospitals
- Homecare Settings
- Others
-
Regional Outlook (Revenue, USD Billion; 2020-2035)
- North America
- United States
- Canada
- Mexico
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Benelux
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East and Africa
- Saudi Arabia
- UAE
- South Africa
- Turkey
- Rest of MEA
- North America
One of the key strengths of Emergen Research’s content is its commitment to providing up-to-date information. Markets are constantly changing due to technological advancements, economic shifts, and evolving consumer preferences. By regularly updating its research, Emergen Research ensures that businesses always have access to the latest insights. This allows organizations to remain agile and adapt quickly to new developments.
Another important advantage of this research is the inclusion of expert perspectives. The analysts behind the report bring years of experience and a deep understanding of industry trends. Their ability to interpret complex data and identify meaningful patterns adds significant value to the content. These insights not only help businesses understand current market conditions but also prepare for future challenges and opportunities.
Emergen Research also emphasizes clarity and usability in its content. The information is presented in a structured and easy-to-understand format, making it accessible even to those who may not have a strong background in market analysis. This user-friendly approach ensures that businesses of all sizes can benefit from the research.
Browse Full Report Description + Research Methodology + Table of Content + Infographics @ https://www.emergenresearch.com/industry-report/continuous-glucose-monitoring-market
About Emergen Research
Emergen Research is a leading market research and consulting company that provides syndicated reports, customized research solutions, and expert consulting services. The company focuses on helping businesses understand market trends, analyze consumer behavior, and identify growth opportunities. With a strong commitment to accuracy and quality, Emergen Research continues to support organizations in making informed and strategic decisions.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: https://www.emergenresearch.com/
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com